SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15264242
Source:
http://linkedlifedata.com/resource/pubmed/id/15264242
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017262
,
umls-concept:C0033572
,
umls-concept:C0086418
,
umls-concept:C0185117
,
umls-concept:C0205195
,
umls-concept:C0597357
,
umls-concept:C1280500
,
umls-concept:C1515985
,
umls-concept:C2911684
pubmed:issue
4
pubmed:dateCreated
2004-7-20
pubmed:abstractText
This study was designed to determine whether androgen ablation (AA) affects expression of alpha1A-adrenergic receptors (AR) in the human prostate.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15264242-15758773
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8101368
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ADRA1A protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Flutamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha-1
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0270-4137
pubmed:author
pubmed-author:BenaimElie AEA
,
pubmed-author:KaramJose AJA
,
pubmed-author:LinVictorV
,
pubmed-author:McConnellJohn DJD
,
pubmed-author:RoehrbornClaus GCG
,
pubmed-author:SoboorianM HosseinMH
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
310-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15264242-Aged
,
pubmed-meshheading:15264242-Androgen Antagonists
,
pubmed-meshheading:15264242-Antineoplastic Agents, Hormonal
,
pubmed-meshheading:15264242-Flutamide
,
pubmed-meshheading:15264242-Humans
,
pubmed-meshheading:15264242-Leuprolide
,
pubmed-meshheading:15264242-Male
,
pubmed-meshheading:15264242-Middle Aged
,
pubmed-meshheading:15264242-Prostatic Hyperplasia
,
pubmed-meshheading:15264242-Prostatic Neoplasms
,
pubmed-meshheading:15264242-RNA, Messenger
,
pubmed-meshheading:15264242-Receptors, Adrenergic, alpha-1
,
pubmed-meshheading:15264242-Reverse Transcriptase Polymerase Chain Reaction
pubmed:year
2004
pubmed:articleTitle
The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate.
pubmed:affiliation
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Elie.Benaim@UTSouthwestern.edu
pubmed:publicationType
Journal Article
,
Clinical Trial